Israel Englander Capricor Therapeutics, Inc. Call Options Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
71Shares Held
6.3MCall Options Held
210KPut Options Held
526K-
Black Rock Inc. New York, NY1.63MShares$29.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$28.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA642KShares$11.7 Million0.0% of portfolio
-
State Street Corp Boston, MA401KShares$7.31 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ162KShares$2.96 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $444M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...